Drugs / Pentabiocel
last change Dec 2025 re-read 3 minutes ago

Pentabiocel

Developed for
irritable bowel syndrome
Investigated by
University of Roma La Sapienza

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT06720805 Dec 2024 → Jul 2025 overdue irritable bowel syndrome University of Roma La Sapienza Not yet recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Pentabiocel ClinicalTrials.gov intervention name — accepted as the source's own label NCT06720805 ↗